Edwards Lifesciences Corporation(EW) Q3
EPS: 0.8 USD; Forecast 0.74 USD
Revenue: 1.72B USD; Forecast 1.68B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-11-04
Faster global financial news!
Edwards Lifesciences Corporation(EW) Q3: EPS 0.8 USD (above forecast), Revenue 1.72B USD (above forecast)
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
SK hynix is up 5.44% from its previous close, currently trading at ₩1,474,000.
-
2
Overview of Leading Cryptocurrency Trading Platforms and Selection Criteria
-
3
SK Hynix fell 5.15% from its previous close, currently trading at ₩1,326,000.
-
4
OKX App Latest Version and Overview of Leading Cryptocurrency Trading Platforms
-
5
What is IOTX? Analysis of IoTeX’s Project Positioning, Progress, and Risks
-
6
FRUIT Token (FRTS) Trading Guide: Where to Buy and How to Trade
-
7
PSB Token: Planet Sandbox Project Analysis and Current Market Status
-
8
On-chain investigator ZachXBT reveals: French bank Crédit Mutuel Arkéa may have lost over $133 million due to crypto theft
-
9
Is ALLIN Worth Holding Long-Term? Current Status, Risks, and Decision Framework
-
10
Trump downplays speculation of strike on Iran, but says US is "locked and loaded" while stating there are no immediate strike plans and negotiations are underway
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
